CTOs on the Move


 
Built on the legacy of James Edward Hanger, the first amputee of the American Civil War, Hanger, Inc. (NYSE: HGR) delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market. Hanger`s Patient Care segment is the largest owner and operator of O&P patient care clinics with in excess of 730 locations nationwide. Through its Products and Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides therapeutic solutions. Steeped in over 150 years of clinical excellence and innovation, Hanger`s vision is to be the partner of choice ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.hanger.com
  • 10910 Domain Drive Suite 300
    Austin, TX USA 78758
  • Phone: 512.777.3800

Executives

Name Title Contact Details
Lety Nettles
EVP Chief Information Officer Profile
Caleb Magee
Chief Information Security Officer Profile
Alan Mitchell
Chief Information Security Officer Profile
Alan Mitchell
Vice President of Security and Infrastructure and Chief Information Security Officer Profile
Scott Ranson
Chief Information Officer Profile

Funding

Hanger raised $605M on 03/05/2018

Similar Companies

pSivida

pSivida is a leading provider of miniaturized, sustained-release drug delivery products and is continuing the evolution of these systems.

Buffalo Valley Inc

BVI has been providing affordable alcohol/substance abuse treatment to patients in need for more than twenty-three years now. Of those 23 years, I have had the privilege of directing that treatment for over 14 years. In the early days we treated about

WebOps

WebOps is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MRI Interventions

MRI Interventions, Inc. is a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI, guidance. Since our inception in 1998, we have focused on research and product development in the field of interventional MRI. From 1998 to 2002, we deployed significant resources to fund our efforts to develop the foundational capabilities for enabling MRI-guided interventions and to build an intellectual property position. In 2003, our focus shifted to identifying and building out commercial applications for the technologies we developed in prior years. We have two product platforms. Our ClearPoint® system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. Our ClearTrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. Both systems utilize intra-procedural magnetic resonance imaging to guide the procedures. Both systems are designed to work in a hospital’s existing MRI suite. Our products are designed to provide a new, minimally invasive surgical approach for the benefit of large patient populations. Our ClearPoint system is designed to enable the delivery of therapies to treat certain neurological diseases. Our ClearTrace system is designed to deliver therapies to treat certain cardiac diseases. We believe that our two product platforms, subject to appropriate regulatory clearance and approval, will provide better patient outcomes, enable physicians and hospitals to treat more patients, and reduce costs to the healthcare system.

Mentholatum Company

Mentholatum Company is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Mentholatum Company is based in Orchard Park, NY. You can find more information on Mentholatum Company at www.mentholatum.com